	US 12,409,212 B2
	Immunogenic gel compositions
Joel Lee Nerem, Edgerton, MN (US); Daniel Brian Hanson, Edgerton, MN (US); Fernando Lopes Leivas Leite, Atlanta, GA (US); Justin Howard Rustvold, Dacula, GA (US); and Amanda Marie Sponheim, Osage, IA (US)
Filed by BOEHRINGER INGELHEIM VETMEDICA GMBH, Ingelheim am Rhein (DE)
Filed on Oct. 28, 2022, as Appl. No. 18/050,577.
Claims priority of provisional application 63/266,984, filed on Jan. 21, 2022.
Claims priority of provisional application 63/264,615, filed on Nov. 29, 2021.
Claims priority of provisional application 63/263,360, filed on Nov. 1, 2021.
Prior Publication US 2023/0141226 A1, May 11, 2023
Int. Cl. A61K 39/02 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 39/112 (2006.01); A61P 31/04 (2006.01); A61K 39/00 (2006.01)

CPC A61K 39/0275 (2013.01) [A61K 9/0053 (2013.01); A61K 9/06 (2013.01); A61K 39/0208 (2013.01); A61P 31/04 (2018.01); A61K 2039/522 (2013.01); A61K 2039/542 (2013.01); A61K 2039/545 (2013.01); A61K 2039/552 (2013.01)]

23 Claims

1. An immunogenic gel composition comprising a modified live Lawsonia intracellularis and a modified live Salmonella spp. and a gel composition suitable for application within the barn or housing environment to be accessible to an animal for consumption, wherein the gel composition comprises water, an adhesion enhancing agent, a stabilizer, a flavoring agent, and a colorant, wherein the adhesion enhancing agent is a maltodextrin and/or a cellulose and/or starch and/or a gum.